SUNDAY, JUNE 25, 2023 (CONTINUED) 4:30 p.m.-6:00 p.m. sessions (*) Current Controversies in the Primary Prevention of Diabetes Macrovascular Complications (Includes Livestream) Creating a World without Visual Loss from Diabetes (*) Let's Talk Treatment-Discussing Options for Weight and Diabetes Management Joint ADA/ADCES Symposium-Implementing Technology into a Busy Practice- It Takes a Village! (Includes Livestream) Time-in-Range-Where Are We Headed in 2023? (Includes Livestream) Improving Outcomes for Adolescents with Type 2 Diabetes (*) Oral Semaglutide for Treatment of Obesity and Type 2 Diabetes-Results from OASIS 1 and PIONEER PLUS Trials (Includes Livestream) Glucose Monitoring Technologies The Ongoing Impact of the DCCT/EDIC Study at 40 Years Cellular Cross Talk Regulating Insulin Action How Sex Shapes Metabolism and Glucose Homeostasis Beta-Cell Identity from Prenatal Life to Death Controlling the Communicators-Cytokine-Specific Therapies to Preserve Beta-Cell Function in Type 1 Diabetes Chrononutrition for the Prevention and Treatment of Diabetes Maximum total credit for 4:30 p.m.-6:00 p.m. sessions Maximum total credit for Sunday 1.5 8 Total Attended credit ❑3 ❑ ❑ ❑ ❑ ❑ ❑ ❑ ❑ ❑ ❑ ❑ ❑ ❑ ❑ (*) Denotes ANCC pharmacotherapeutics contact hours. 59